1,770 results on '"Giladi, Nir"'
Search Results
2. Decreased aperiodic neural activity in Parkinson’s disease and dementia with Lewy bodies
3. Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease
4. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
5. A meta-analysis identifies factors predicting the future development of freezing of gait in Parkinson’s disease
6. Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
7. The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol
8. Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
9. Incidence of cardiovascular morbidity among Parkinson's disease patients; a large-scale cohort study in a 16-year time window around disease onset
10. Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
11. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
12. Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriers
13. Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon
14. Event-related oscillations differentiate between cognitive, motor and visual impairments
15. Daily-Living Freezing of Gait as Quantified Using Wearables in People With Parkinson Disease: Comparison With Self-Report and Provocation Tests
16. Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers
17. Tetanus vaccination is associated with decreased incidence of Parkinson's disease and slower progression
18. P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease
19. Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
20. The interplay between structural and functional connectivity in early stage Parkinson's disease patients
21. Decreased delta-band event-related power in dementia with Lewy bodies with a mutation in the glucocerebrosidase gene
22. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
23. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
24. Stepping up to meet the challenge of freezing of gait in Parkinson’s disease
25. Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
26. Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
27. Hippocampal and non-hippocampal correlates of physically active lifestyle and their relation to episodic memory in older adults
28. Estimation of Genetic Risk Function with Covariates in the Presence of Missing Genotypes
29. Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6‐Item Score.
30. Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
31. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
32. Venglustat in GBA1-related Parkinson's disease – Authors' reply
33. ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
34. Quantitative digital clock drawing test as a sensitive tool to detect subtle cognitive impairments in early stage Parkinson's disease
35. A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson's disease
36. Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease
37. Differential changes in visual and auditory event-related oscillations in dementia with Lewy bodies
38. Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait?
39. Changes in the EEG spectral power during dual-task walking with aging and Parkinson’s disease: initial findings using Event-Related Spectral Perturbation analysis
40. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
41. MAPT Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified Analysis
42. Overnight Distribution of REM Sleep Features in People with Parkinson’s Disease (PD) and Non-PD Controls
43. Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
44. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project
45. REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers
46. Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults
47. Neural Variability in the Prefrontal Cortex as a Reflection of Neural Flexibility and Stability in Patients With Parkinson Disease
48. Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
49. Higher Frequency of Certain Cancers in LRRK2 G2019S Mutation Carriers With Parkinson Disease: A Pooled Analysis
50. Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill®) in Parkinson's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.